Biotech

All Articles

A better consider Fierce Biotech's Brutal 15

.Within this full week's episode of "The Leading Pipe," our experts're diving right into Ferocious B...

Lilly deals with period 2 failure of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's party celebrating the commendation o...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of notable management hirings, firings and retir...

Lykos will certainly inquire FDA to rethink its selection observing rejection of MDMA therapy for trauma

.Adhering to a bad presenting for Lykos Therapeutics' MDMA applicant for trauma at a current FDA adv...

AN 2 halves roll call, stops stage 3 test after data disappoint

.AN2 Therapies is rethinking its own business in reaction to lackluster midphase data, vowing to lay...

Merck pays out $700M for bispecific, spying autoimmune opening and also odds to test Amgen in cancer cells

.Merck &amp Co. is actually paying for $700 thousand upfront to test Amgen in a blood stream cancer ...

Gilead spends J&ampJ $320M to go out licensing offer for seladelpar

.Along With Gilead Sciences about to an FDA selection for its own liver condition medicine seladelpa...

' All palms on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks can easily see the business setting up camping tents at basecam...

Entero laying off staff, leaving office and also stopping briefly R&ampD

.Cushion Liquidators has actually transformed Entero Therapeutics white as a slab. The creditor orde...

Exelixis drops ADC after determining it's no match for Tivdak

.Exelixis is actually giving up on its own tissue factor (TF)- targeting antibody-drug conjugate aft...